StonvexLoading…
StonvexCore line items from HRTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-06 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $43.04M | $34.71M | $154.90M | $114.32M | $76.10M |
Operating Income | Not available | $-4.76M | $-2.54M | $-2.58M | $1.52M |
Net Income | Not available | $-8.11M | $-20.20M | $-17.24M | $-2.38M |
EPS (Diluted) | $0.01 | $-0.04 | $-0.12 | $-0.11 | $0.00 |
Total Assets | Not available | $246.22M | $255.88M | $248.95M | $232.09M |
Total Liabilities | Not available | $237.08M | $241.54M | $234.06M | $259.35M |
Cash & Equivalents | Not available | $26.12M | $28.65M | $43.07M | $16.52M |
Free Cash Flow OCF − CapEx | Not available | $-1.93M | $-27.91M | $-18.72M | $-20.05M |
Shares Outstanding | Not available | 189.65M | 188.31M | 159.52M | 197.75M |